Stop-loss on the minds of SMSPHARMA investors as it underperforms broader market
23 Mar, 20265 min read
SMSPHARMA delivered lacklustre performance today. On a longer term basis, investors in SMS PHARMACEUTICALS LTD. made +0.05% per day. Monday's performance of -4.23% was a significant underperformance compared to it's daily average.